Improved Overall Survival with Axicabtagene Ciloleucel Vs Standard of Care in Second-Line Large B-Cell Lymphoma Among the Elderly: A Subgroup Analysis of ZUMA-7

Introduction: Historically, older patients (pts) with relapsed/refractory large B-cell lymphoma (R/R LBCL) were often deemed ineligible for curative-intent autologous stem cell transplant (ASCT) due to age and concern for increased toxicity related to comorbidities. We previously demonstrated in the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.1761-1761
Hauptverfasser:	Kersten, Marie José, Farooq, Umar, Rapoport, Aaron P., Locke, Frederick L., Leslie, Lori A., Ghobadi, Armin, Miklos, David B., Jacobson, Caron A., Munoz, Javier L., Johnston, Patrick B, Jaglowski, Samantha M., Flinn, Ian W., van Meerten, Tom, Perales, Miguel-Angel, Vandenberghe, Peter, Riedell, Peter A., Dorritie, Kathleen, Szwajcer, David, Tzachanis, Dimitrios, Vardhanabhuti, Saran, Du, Linqiu, Filosto, Simone, Shahani, Shilpa A., To, Christina, Westin, Jason
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!